Introduction
A variety of steroids with unusual and interesting structures have been isolated from marine sponges, recently [1] [2] [3] . Among these steroidal compounds, marine steroids with oxime groups have been reported rarely. In 1997, two steroidal oximes, (6E)-hydroximino-24-ethylcholest-4-en-3-one (1) and (6E)-hydroximinocholest-4-en-3-one (2), were isolated from Cinachyrella alloclada and C. apion [4] . In 2005, another steroidal oxime, (3E)-hydroximinocholest-4-en-6-one (3), was isolated from Cinachyrella australiensis [5] . These steroids exert interesting biological activities [6] . For example, bioassays showed that compound 3 functions against hepatitis virus in vitro [5] and compound 2 exhibitted a selective cytotoxic activity against several types of cancer cells such as P-388, A-549, HT-29 (IC 50 : 1.25 g/mL) and MEL-28 tumor cells (IC 50 : 2.5 g/mL) [7] . In this paper, a facile and efficient synthetic method for the compound 1, 2 and 4 is reported.
Experimental

Chemistry
The sterol and NaBH 4 were purchased from the Merck Co. All chemicals and solvents were analytical grade and solvents were purified by general methods before being used. Melting points were determined on an X 4 apparatus and were uncorrected. Infrared spectra were measured with a Nicolet FT-360 Spectrophotometer. The 1 H and 13 CNMR spectra were recorded in CDCl 3 on a Bruker AV-500 spectrometer at working frequencies 500 and 125 MHz, respectively. Chemical shifts are expressed in ppm (ı) values and coupling constants (J) in Hz. LREIMS were recorded on a Thermo-DSQ instrument, while HREIMS were measured on a Thermo-MAT95XP instrument. The cell proliferation assay was undertaken by a MTS method using 96-well plates on Beckman coulter LD400 AD/LD analysis spectrometer.
24-Ethylcholest-4-en-3,6-dione (6a)
Pyridinium chlorochromate (PCC) (2.564 g, 11.9 mmol) was added to a solution of sitosterol (5a) (0.852 g, 0.50 mmol) in dried CH 2 Cl 2 (40 mL) in one portion at room temperature. The reaction was completed in 26 h. To the mixture was then added 30 mL of CH 2 Cl 2 , and the suspension was poured over a silica gel column and eluted with CH 2 Cl 2 . The resulting solution was washed with cold water and saturated brines. After drying over anhydrous sodium sulfate, the solvent was removed under reduced pressure, and the resulting crude product was purified by chromatography on silica gel using petroleum ether (60-90 • C)/EtOAc 
24-Ethylcholest-4-en-3ˇ-ol-6-one (7a)
NaBH 4 (30 mg, 0.79 mmol) was added to a solution of 6a (110 mg, 0.25 mmol) and CoCl 2 .6H 2 O (61 mg, 0.26 mmol) in CH 3 OH (15 mL) in the interval of 8 min at room temperature. After 15 min, the reaction was stopped. The solution was neutralized with 1 M HCl. After evaporation of the majority of the MeOH under reduced pressure, ethyl acetate (30 mL) was added to the residue. The resulting solution was washed with cold water and saturated brines. After drying over anhydrous sodium sulfate, the solvent was removed under reduced pressure, and the resulting crude product was purified by flash chromatography on silica gel using petroleum ether/ethyl acetate (2:1) 
Cholest-4-en-3ˇ-ol-6-one (7b)
Yield
24-Ethylcholest-4,22-dien-3ˇ-ol-6-one (7c)
(6E)-Hydroximino-24-ethylcholest-4-en-3ˇ-ol (8a)
7a (150 mg, 0.40 mmol) was dissolved in 15 mL 95% CH 3 CH 2 OH. After the mixture was heated to 55 • C, CH 3 COONa·3H 2 O (95 mg, 0.70 mmol) and NH 2 OH • HCl (60.6 mg, 0.87 mmol) were added. The mixture was stirred at the temperature for 1.5 h. Then the reaction was terminated and the majority of solvent was evaporated under reduced pressure. Proper water was added into the reaction mixture, and the product was extracted with ethyl acetate (3 mL × 20 mL). The combined extracts were washed with saturated brine, dried, and evaporated under reduced pressure. The residue was subjected to chromatography to give 109 mg of 8a 
(6E)-Hydroximino-24-ethylcholest-4,22-dien-3ˇ-ol (8c)
(6E)-Hydroximino-24-ethylcholest-4-en-3-one (1)
The Jones' reagent of 0.5 mL (0.267 mol/L) was added dropwise to the solution of 8a (73 mg, 0.164 mmol) in 10 mL of acetone in 10 min. The reaction mixture was stirred at room temperature for 1 h and then neutralized with 10% K 2 CO 3 solution. The suspension was poured over a silica gel column and eluted with ethyl acetate. The solvent was removed under reduced pressure. The residue was chromatographed on silica gel using petroleum ether (60-90 The similar method was used for synthesizing the compounds 2 and 4. Therefore, only experimental details for the synthesis of compound 1 are reported.
(6E)-Hydroximinocholest-4-en-3-one (2)
Antiproliferative activity
Materials and methods
Stock solutions of compounds 1, 2 and 4, were prepared in sterile dimethyl sulfoxide (DMSO) (Sigma) at a concentration of 10 mg/mL and afterwards diluted with complete nutrient medium (RPMI-1640) supplemented with 10% heat inactivated fetal bovine serum and 0.1 g/L penicillin G + 0.1 g/L streptomycin sulfate.
Cell culture
Sk-Hep-1, H-292, PC-3 (ATCC) and Hey-1B (a gift from Dr. Yan Xu, University of Indiana) cells were cultured in a proper medium supplemented with 10% fetal bovine serum in a humidified atmosphere of 5% CO 2 at 37 • C.
Treatment of cancer cells
Cancer cells (4 × 10 3 cells/200 L) were seeded into each well of a 96-well microtiter plate. After incubation for 24 h, the compounds with a series of concentrations (range 20-80 g/mL) were added to the cells. An equal amount of DMSO was added to the cells used as negative controls. All were treated in triplicate.
Determination of cell viability
MT Stetrazolium salt (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) (CellTiter 96 AQ ueous Non-Radioactive Cell Proliferation Assay, Cat.# G5421, Promega Corporation) dye reduction assay was used. The assay is dependent on the MTS being reduced to an aqueous, soluble formazan by dehydrogenase enzymes found in metabolically active cells. The quantity of formazan product as measured by the amount of 490 nm absorbance is directly proportional to the number of living cells in culture. Briefly, after treatment (see Section2.2.3) for 72 h, the medium was removed and the cells were incubated with 100 L of fresh medium plus 20 L of MTS solution according to the instruction for additional 4 h. The absorbance (A) at 490 nm was measured using an Beckman coulter LD400 AD/LD analysis spectrometer. IC 50 concentration was defined as the concentration of an agent inhibiting cell survival by 50%, compared to a control.
Results and discussion
The initial studies for the synthesis of this kind of oximesteroid system were based on the methodology developed by Holland et al. [8] . Seven steps were needed to synthesize compound 1 as reported in reference [4] . Later Kovganko et al. reported two new synthesis routes for the compound 1, both were rather complicated and the overall yields were relatively low [9, 10] . Here, we introduce a new synthetic method for the steroidal oxime compound 1, 2 and 4 with higher overall yields and fewer synthetic steps. For example, using ␤-sitosterol as raw material, four steps are needed for synthesizing the compound 1 with an overall yield of 33%. The synthesis route of the compound 1, 2 and 4 is as shown in Fig. 1.   Fig. 1 -The synthesis of some (6E)-hydroximino-4-en-3-one steroids. (a) In step1, ␤-sitosterol (5a) is transformed into the corresponding 24-ethylcholest-4-en-3,6-dione (6a) via oxidation with PCC in CH 2 Cl 2 in 86% yield. Selective reduction of 6a by NaBH 4 in the presence of CoCl 2 gives 24-ethylcholest-4-en-3␤-ol-6-one (7a) in 85% yield according to the synthetic method we developed [11] . The structure of 7a was confirmed by comparing IR and 1 H NMR spectra with those of the analogous compound that was synthesized previously in Ref. [12] .
Next, the oxime 8a is obtained by the reaction of 7a with hydroxylamine hydrochloride in ethanol in the presence of NaOAc in 75% yield. The structure of 8a was proved by spectral data. At the same time, cis-isomer 9a of 8a was obtained in 9.5% yield.
Oxidation of 8a by Jones' reagent in acetone gives the target steroid 1 in 69% yield. The IR and 1 H NMR spectra data of 1 are perfectly consistent with those of the natural compound 1.
The compound 2 and 4 were prepared in the similar synthetic method to the compound 1.
To determine the biological activity of these compounds, we investigated their ability against four human tumor cell lines: Sk-Hep-1 (human liver carcinoma), H-292 (human lung carcinoma), PC-3 (human prostate carcinoma) and Hey-1B (human ovarian carcinoma). The results, expressed as IC 50 values in g/mL, are reported in Table 1 .
Our results showing in the Table 1 revealed that the compound 2 and 4 displayed a modest cytotoxic activity against these cancer cells. Interestingly the structure of side chains on these steroidal oximes plays an important role in their cytotoxicity. The antineoplastic activity of these compounds increases along with the order of the side chain attached: cholesterol-like side chain(2) > stigmasterollike side chain(4) > sitosterol-like side chain (1) . The presence of a cholesterol-type side chain appears to be necessary for the biological activity. This is consist with the conclusion obtained by Rodríguez et al. [7] .
